A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2017
At a glance
- Drugs TPX 100 (Primary)
- Indications Osteoarthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors OrthoTrophix
- 07 Nov 2017 Results (n = 93) presented in an OrthoTrophix media release.
- 07 Nov 2017 Results from this trial (n =93) were presented at the 2017 American College of Rheumatology (ACR/ARHP) Annual Meeting, according to an OrthoTrophix media release.
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History